Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01843283 · ClinicalTrials.gov registry record · Phase 1
Meaningful Activity Intervention for Persons With Mild Cognitive Impairment
A Phase 1 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01843283: Completed Phase 1 study, sponsored by Indiana University.
NCT01843283 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01843283, a Phase 1 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the feasibility of and satisfaction with the revised DEMA and to estimate effect sizes for DEMA through incorporation of a comparison group. Specific aims are as follows: Aim 1: Evaluate feasibility of the study for MCI patient/caregivers. Aim 2: Estimate effect sizes for DEMA on MCI patient and caregiver outcomes. Aim 3: Evaluate MCI patients and family caregivers' satisfaction with and perceptions of DEMA or IS.
Interventions
- BEHAVIORAL Daily Enhancement Meaningful Activity (DEMA)
- BEHAVIORAL Information Support (IS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
What the finished NCT01843283 record still lists
NCT01843283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 2 interventions - of which Daily Enhancement Meaningful Activity (DEMA) is the first listed.
NCT01843283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01843283 about?
NCT01843283 is a clinical study titled "Meaningful Activity Intervention for Persons With Mild Cognitive Impairment". The purpose of this pilot study is to evaluate the feasibility of and satisfaction with the revised DEMA and to estimate effect sizes for DEMA through incorporation of a comparison group. Specific aims are as follows: Aim 1: Evaluate feasibility of the study for MCI patient/caregivers. Aim 2: Estim...
What is the current status of trial NCT01843283?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2012-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01843283?
The interventions under investigation include: Daily Enhancement Meaningful Activity (DEMA) (BEHAVIORAL), Information Support (IS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01843283?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01843283's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia